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Background:  Non-alcholic steatohepatitis (NASH) is increasingly recognized as a cause of liver failure, with an increasing number of patients 
being evaluated for liver transplantation (LT). Because of increased body mass (BMI) and abnormal lipid profiles, NASH patients may have a higher 
prevalence of occult coronary artery disease (CAD). Dobutamine stress real time perfusion echocardiography (DSRTPE) improves the detection of 
CAD in LT candidates, and we hypothesized that DSRTPE may improve the detection of CAD in NASH patients. 
Methods:  DSRTPE was performed in 183 patients referred for LT evaluation (107 with NASH, 76 with other causes for liver failure: non-NASH). 
Baseline ejection fraction (LVEF), transmitral E and e’, E deceleration time (EDT), were also recorded. Regional wall motion (WM) and myocardial 
perfusion (MP) were assessed using a 17 segment model during a continuous infusion of ultrasound contrast and low mechanical index imaging.
Results:  Patients with NASH had larger BMI (34+ 7kg/m2 NASH versus 30+6 kg/m2 non-NASH;p<0.001), and were more frequently female 
(p=0.013), but were not different with respect to age or history of CAD compared to non-NASH patients. Both diabetes (p=0.04) and hyperlipidemia 
(p=0.009) were more prevalent with NASH. There were no differences between groups in LVEF, transmitral E/e’, or EDT. NASH patients, however, had a 
higher frequency of inducible MP defects (25% versus 16%; p<0.05). The extent of inducible MP defects was also larger (2.5+1.1 segments for NASH 
versus 1.9+0.9 segments for non-NASH patients; p<0.001). MP defects occurred in the absence of WM abnormalities in 18 of the 27 abnormal 
NASH studies (67%). Despite higher abnormalcy rates, the positive predictive value of DSRTPE for NASH patients, when correlated with angiography, 
was the same as non-NASH patients (63%).
Conclusions:  These data indicate that NASH patients undergoing LT evaluation have a higher prevalance of significant CAD, and a greater extent 
of inducible ischemia.These abnormalities are detectable only if perfusion is analyzed with wall motion when using DSRTPE. NASH patients, therefore, 
may be at higher risk for CAD complications following liver transplantation.
